about
Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysisNormal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?Novel strategies: challenge loop diuretics and sodium management in heart failure--part II.Beta-blockers and ivabradine in chronic heart failure: from clinical trials to clinical practice.Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction.Impact of ''off-label'' use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure.Presence of antinuclear antibodies and coronary heart disease.Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings.Tako-tsubo cardiomyopathy and microcirculation.Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin.Sensitivity, specificity and predictive value of the echocardiography and troponin-T test combination in patients with non-ST elevation acute coronary syndromes.Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind stCardiovascular effects of I/D angiotensin-converting enzyme gene polymorphism in healthy subjects. Findings after follow-up of six years.Multiple arterial grafting and ostriches: let's all take heart!Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey.Spinal cord stimulation for the treatment of refractory angina pectoris: a multicenter randomized single-blind study (the SCS-ITA trial).Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients.Heart rate turbulence for guiding electric therapy in patients with cardiac failure.Safety and feasibility of atropine added in patients with sub-maximal heart rate during exercise myocardial perfusion SPECT.Relationship between ACE-DD polymorphism and diastolic performance in healthy subjects.Value of negative predischarge exercise testing in identifying patients at low risk after acute myocardial infarction treated by systemic thrombolysis.Isolated left ventricular non-compaction: A larger part of submerged iceberg with criteria for diagnosis to the limits of standardExercise training in patients with Chronic Heart Failure: a new challenge for Cardiac Rehabilitation CommunityImpaired pain processing in patients with silent myocardial ischemiaThe Role of Ivabradine in Cardiac Rehabilitation in Patients With Recent Coronary Artery Bypass GraftThe old and new tests for celiac disease: which is the best test combination to diagnose celiac disease in pediatric patients?Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compensated Heart Failure With New York Heart Association Class III (Class C) (SMAC-HF Study)Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findingsEfficacy of rescue thrombolysis in patients with acute myocardial infarction: preliminary findingsUtility and safety of immediate exercise testing of low-risk patients admitted to the hospital with acute chest painExercise thallium scintigraphy versus high-dose dipyridamole echocardiography testing for detection of asymptomatic restenosis in patients with positive exercise tests after coronary angioplastyEarly Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction[Did household parental smoking attitude change over the last 15 years? A survey among primary school children in the city of Agrigento, Italy]Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional ImprovementOncology and Cardiac Rehabilitation: An Underrated RelationshipSacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction
P50
Q28166387-055B2800-664E-40E9-9E1F-87486D8C4C20Q34661356-CF1CE7A3-E39E-4A5F-B0E2-062C63AE3F4CQ36836560-ACF0B3E4-A6D8-41BD-B88A-4886F0293D2AQ38170307-6F982CCA-7365-49AD-931F-947AC9229FAFQ42164977-5DFA63A4-2F60-4587-9247-819C6D18D6E5Q42861006-DBD745C8-6094-429C-9443-74038E474DB5Q42874010-EF0229A6-4405-45C5-90CC-C7CA2DBF1677Q43234439-BB3F87B1-A53E-4BBE-812B-A18959D6898DQ43771719-3B8A0962-E35F-4082-9C32-BE830975C10EQ43802931-B72E11EB-FCC1-4A06-B958-B0C15FE6BBC9Q44376288-83B53EB2-4AAA-4730-B1F4-F2D088EA0145Q46187189-F95D7970-1E0A-44A4-9FBC-D7111E97A825Q46553127-D5133B76-DE46-4256-8BD5-F4F284B8A551Q46674673-1D267612-1A78-4417-9D3D-FD1BED394C6EQ47138474-7C1F3ECB-F313-4FB6-9FEF-2354F05B481DQ47295481-DAD4F8A3-31C3-478D-9CC2-B6CCFD85A796Q48758673-596653BD-E7D1-4722-AED8-BAF40A22BCF0Q50902632-80D26DA4-BB77-4B9C-9460-9E26BFA35F9CQ51728534-305F6A8B-170F-4BC4-BD76-B2A98F95E172Q53512165-DE97D453-5B06-488B-B0FC-4B27BC1DE68BQ53735379-086BB76F-B0CF-4E47-A26B-BAFE6AA7C7E7Q54708640-45AA6C8F-9EF4-4772-A7CD-43EC1C050E3CQ60461403-8C5858E8-B1B1-41F2-A1A2-E861FBEE2746Q60733824-74D1972A-2C27-4679-9DD0-864150162819Q60733850-1FB3C795-F38A-4A42-BA49-15B34EFCD35AQ60733856-83D59627-BFFA-4BE6-A543-2ABDC03732E1Q60733883-527EE4B7-A8C2-4A00-85E7-A06D18A81BD2Q60733887-66BB2D0B-1515-42DF-8604-A4931FBAB7A5Q60733922-962CB90D-D124-439B-BF1B-72F223C880CFQ60733949-E040B430-F25E-47AE-8110-E4F3EDCBBC6BQ60733954-5B18B0FB-CAE1-4BF4-9C7B-0BFB7E42F84CQ60733959-678E2751-EFF3-4425-8FE5-DA791EABD32AQ64245152-62B5A605-6FA0-45F8-A011-0F8BCA37D7B4Q85574375-3491A64D-044B-4FCE-AA8D-1370EA0AD7ADQ94459545-D9F0416D-196F-46FC-ABBB-F96C0E89F1A3Q96345483-E62B0A95-156B-444C-A514-B4EE6D8A639AQ96604595-93791EF8-D86E-40B3-A320-B89E7615F314
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Filippo M. Sarullo
@ast
Filippo M. Sarullo
@en
Filippo M. Sarullo
@es
Filippo M. Sarullo
@nl
Filippo M. Sarullo
@sl
type
label
Filippo M. Sarullo
@ast
Filippo M. Sarullo
@en
Filippo M. Sarullo
@es
Filippo M. Sarullo
@nl
Filippo M. Sarullo
@sl
prefLabel
Filippo M. Sarullo
@ast
Filippo M. Sarullo
@en
Filippo M. Sarullo
@es
Filippo M. Sarullo
@nl
Filippo M. Sarullo
@sl
P106
P1153
6603759433
P21
P31
P496
0000-0003-2046-8316